Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008255 · ClinicalTrials.gov registry record · Phase 2
INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00008255: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00008255 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00008255, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Doctors can diagnose lung cancer by collecting mucus coughed up from the lungs and examining it under a microscope to look for cancer cells. Breathing in INS316 may make it easier for patients to cough up mucus. PURPOSE: Randomized phase II trial to study the effectiveness of INS316 in helping to diagnose lung cancer.
Interventions
- OTHER sputum cytology
- DRUG INS316
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
What the finished NCT00008255 record still lists
NCT00008255 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which sputum cytology is the first listed.
NCT00008255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00008255 about?
NCT00008255 is a clinical study titled "INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer". RATIONALE: Doctors can diagnose lung cancer by collecting mucus coughed up from the lungs and examining it under a microscope to look for cancer cells. Breathing in INS316 may make it easier for patients to cough up mucus. PURPOSE: Randomized phase II trial to study the effectiveness of INS316 in h...
What is the current status of trial NCT00008255?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-08. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00008255?
The interventions under investigation include: sputum cytology (OTHER), INS316 (DRUG).
Who is sponsoring clinical trial NCT00008255?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia